A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease
Clinical trial NCT07120152 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07120152
- Sponsor
- Erwin Dreesen
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 439
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.